Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells

Abstract

Previously, a growth inhibiting effect of PC-Spes on head and neck carcinoma cell lines had been demonstrated. In order to determine the toxic impact of particular herbs in the mixture, we exposed the head and neck cancer cell lines FADU, HLaC79 and its Paclitaxel-resistant subline HLaC79-Clone1 as well as primary mucosal keratinocytes to increasing concentrations of the herbal mixture Prostaprotect, which has a similar formulation as PC-Spes, as well as its single herbal components Dendranthema morifolium, Ganoderma lucidium, Glycyrrhiza glabra, Isatis indigotica, Panax pseudo-ginseng, Rabdosia rubescens, Scutellaria baicalensis and Pygeum africanum. Growth inhibition was measured using the MTT assay. Expression of P-glycoprotein (P-GP), multidrug resistance protein-1 (MRP-1), multidrug resistance protein-2 (MRP-2), breast cancer resistance protein (BCRP) and androgen receptor (AR) were examined by western blot analysis. Pygeum africanum extract clearly turned out as the main cytotoxic component of the Prostaprotect prescription mixture, and initated apoptosis in sensitive cell lines. All other extracts had only minor toxic effects. Western blot analysis revealed increased expression of P-GP in HLaC79-Clone1 cells, while HLaC79 and FADU cells were negative. All three cell lines were negative for MRP-1 and BCRP but positive for MRP-2. HLaC79 and its descendant HLaC79-Clone1 both expressed AR, as verified by western blotting and immunofluorescence staining. Primary mucosal keratinocytes were negative for all multidrug resistance markers as well as for AR. Growth inhibition rates of the single herbal extracts were compared with previously published results in prostate carcinoma cell lines. The relationship between expression levels of AR and multidrug resistance markers in relation to the measured toxicity of herbal extracts in our head and neck cancer cell system is critically discussed.

Comparative Cytotoxicity of Glycyrrhiza glabra Roots from Different Geographical Origins Against Immortal Human Keratinocyte (HaCaT), Lung Adenocarcinoma (A549) and Liver Carcinoma (HepG2) Cells

“…However, Schmidt et al . () evaluated the cytotoxicity of herbal extracts, G . glabra being one of those, used for treatment of prostatic disease on head and neck carcinoma cell lines and non‐malignant primary mucosal cells, and Yo et al .…”

Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease

“…The Asteraceae plant family is the largest plant family known, to date, that has sesquiterpene lactones (SL) as chemical markers (10,11). Some of these lactones have been tested in vitro and in vivo and showed significant anti-T. cruzi activities (12,13).…”

Characterization and anti‐acute T cell leukemia properties of silver nanoparticles synthesized by a green approach for bioremediation applications: Introducing a new chemotherapeutic drug for clinical trial studies

“…Researchers have evaluated the cytotoxicity of polyphenol molecule extracted from Glycyrrhiza glabra which is used for the treatment of breast and prostate cancer, head and neck cancer cell lines and non‐malignant primary mucosal cells, and against different cancer cell lines such as Immortal Human Keratinocyte (HaCaT), Lung Adenocarcinoma (A549), and Liver Carcinoma (HepG2) cell lines …”

“…ROS‐induced development of cancer involves malignant transformation due to DNA mutations and changed gene expression through epigenetic mechanisms which in turn causes the uncontrolled proliferation of cancerous cells . Also, high levels of ROS are observed in various cancerous cells and several accumulating evidence suggest that ROS function as key signaling molecules stimulate different growth‐related responses that finally begin tumorigenesis and angiogenesis . Several studies showed a remarkable role of antioxidant compounds such as medicinal plants and silver nanoparticles in growth inhibition of endometrium and lung, prostate, breast, ovary, and colon cancer cells with removing ROS …”